Cargando…

Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab

A 35-year-old man with refractory Crohn's disease showed a loss of response to infliximab after requiring treatment with infliximab at 10 mg/kg together with steroid to maintain remission. His symptoms recurred, and colonoscopy showed extensive active ulcers in the colon. Adrenomedullin therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashizuka, Shinya, Kuroishi, Nobuko, Nakashima, Koji, Inatsu, Haruhiko, Kita, Toshihiro, Kitamura, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599938/ https://www.ncbi.nlm.nih.gov/pubmed/30713309 http://dx.doi.org/10.2169/internalmedicine.1791-18

Ejemplares similares

Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
por: Ashizuka, Shinya, et al.
Publicado: (2021)

Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series
por: Ashizuka, Shinya, et al.
Publicado: (2015)

Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)

Effectiveness of Concomitant Enteral Nutrition Therapy and Infliximab for Maintenance Treatment of Crohn’s Disease in Adults
por: Hirai, Fumihito, et al.
Publicado: (2012)

Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins
por: Nagata, Sayaka, et al.
Publicado: (2022)

Adrenomedullin Therapy in Moderate to Severe COVID-19
por: Kita, Toshihiro, et al.
Publicado: (2022)

Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2020)

Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases
por: Kita, Toshihiro, et al.
Publicado: (2022)

Primary Cardiac Leiomyosarcoma: A 27-Month Survival with Surgery and Chemotherapy
por: Nakashima, Koji, et al.
Publicado: (2017)

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial
por: Kita, Toshihiro, et al.
Publicado: (2020)

Salvage photodynamic therapy accompanied by extended lymphadenectomy for advanced esophageal carcinoma: A case report
por: Nishida, Takahiro, et al.
Publicado: (2017)

Effect of a concomitant elemental diet with maintenance anti‐tumor necrosis factor‐α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study
por: Hirai, Fumihito, et al.
Publicado: (2018)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
por: Gouldthorpe, Oliver, et al.
Publicado: (2013)

A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn’s Disease
por: Chen, Yueying, et al.
Publicado: (2021)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
por: Hisamatsu, Tadakazu, et al.
Publicado: (2018)

Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gain
por: Kawano, Sayaka, et al.
Publicado: (2015)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease
por: Feng, Jing, et al.
Publicado: (2022)

Single Rectal Neuroendocrine Tumor Associated with Multiple Endocrine Cell Micronests
por: Suzuki, Sho, et al.
Publicado: (2019)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
por: Chiba, Mitsuro, et al.
Publicado: (2019)

Brain Abscesses in Crohn’s Disease as a Complication of Infliximab Therapy
por: Mansour, Mahmoud M, et al.
Publicado: (2021)

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab
por: Shi, Xuan, et al.
Publicado: (2023)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits
por: Okura, Toshiyuki, et al.
Publicado: (2008)

Maintenance treatment with infliximab for the management of Crohn’s disease in adults
por: Caviglia, Renato, et al.
Publicado: (2009)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
por: Aginbay, Aibar, et al.
Publicado: (2022)

B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy
por: Timmermans, Wilhelmina M. C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k07na3eio17om6srs6jmdpbaju